뒤로
Repare Therapeutics Inc(RPTX) 가격
RPTX 주가 차트
RPTX 배당금
Repare Therapeutics Inc
$2.65
0.76%
$0.02
종가: Jan 27, 16:00:00 GMT-5
$2.64
-0.36%
$0
애프터마켓: Jan 27, 20:00:00 GMT-5
주요 통계
이전 종가
$2.63
시가
$2.64
일일 범위
$2.62 - $2.65
52주 범위
$0.89 - $2.66
거래량
1.1M
평균 거래량
1.1M
EPS(TTM)
-1.69
배당수익률
--
시가총액
$113.5M
RPTX란 무엇인가요?
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company is headquartered in St-Laurent, Quebec and currently employs 129 full-time employees. The company went IPO on 2020-06-19. The firm utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
